智通财经APP讯，国药现代(600420.SH)发布公告，近日，公司全资孙公司江苏威奇达药业有限公司(以下简称“国药江苏威奇达”)收到世界卫生组织(以下简称“WHO”)出具的PQ(预认证)确认函(Confirmation of WHO Active Pharmaceutical Ingredient Prequalification[CPQ])(以下简称“CPQ证书”)，药品名称为：Abacavir Sulfate/硫酸阿巴卡韦。
公告称，硫酸阿巴卡韦主要适用于人类免疫缺陷病毒(HIV)感染的成人，进行抗逆转录病毒的联合治疗。目前，硫酸阿巴卡韦原料药国内主要生产厂商有国药江苏威奇达、湖北恒景瑞化工有限公司、陕西林奈生物化工有限公司等。根据PDB数据，2021年阿巴卡韦原料全球消耗量为98,557.45kg。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.